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Primary extranodal, extralymphatic Hodgkin lymphomas (PEEHLs) are a rare occurrence. When they are encountered, they
become diagnostic challenges. We are describing the uniqueness of a case ofPEEHL aﬀecting the mandible with his early response
to the available chemotherapy.
1.Case
A 68-year-old hispanic male presented with an oral ulcer 1
month after an orthodontic procedure. His complains were
mainly pain at the right inner side of the mouth and adjacent
ipsilateral facial swelling. There was no fever, weight loss, or
other constitutional symptoms referred at presentation. The
lesion and facial edema progressively increased over the last
16 months since the initial presentation. Five biopsies and
ancillary diagnostic tests were unremarkable. Past history
was only positive for cholecystectomy, knee and cataract
surgery. He was then hospitalized for further workup.
Onarrival,his vitalsigns werewithinnormallimits,body
mass indexof29.Thephysicalexamination was onlyrelevant
for the presence of an oral ulcer involving the buccal mucosa
and extending to the edentulous alveolar ridge in the right
posterior mandibular vestibule (Figure 1).
Swelling over the nasogenial sulcus was also noted.
There was no palpable lymphadenopathy or organomegaly.
Complete blood count was only signiﬁcant for normocytic
normochromic anemia with hemoglobin of 11.5g/dL (12–
16g/dL). Other tests including C-reactive protein, liver
enzymes, creatinine, blood urea nitrogen, and lactate dehy-
drogenase were normal. Anemia workup was consistent
with anemia of chronic disease. T1 MRI enhanced with
Gadolinium on a coronal plane is shown (Figure 2)a n d
depicts a heterogeneous enhancement of an inﬁltrative
lesion located at the internal border of the right mandible
associatedwithchangesonthesignalintensityoftheadjacent
bone marrow. Figure 3 (axial T1) also demonstrates altered
bone marrow signal intensity of the right mandible with
disruption of the external bone cortex caused by inﬁltration.
The soft tissue mass component is located at the buccal and
sublingual spaces of the oral cavity. There were no cervical
lymphadenopathies detected. Oral lesion biopsy revealed
through microscopy extensive inﬁltration of the mucosa
for noncohesive lymphoid cells with classic morphology
of Reed-Sternberg (RS) cells in the typical background of
small mature lymphocytes, eosinophils, and plasma cells
(Figures 4(a) and 4(b)). The immunohistochemistry study
of the RS population conﬁrmed the expression of CD30
(Figure 4(c)) and CD15.Epstein-Barr virus was alsodetected
(Figure 4(d)). The RS cells neither expressed CD45, CD20,
E M A ,A L K ,n o rTc e l lm a r k e r ss u c ha sC D 3 ,C D 5 ,C D 4 ,
and CD8. Antiviral capsid antigen immunoglobulin (Ig)
G against Epstein-Barr virus (EBV) was positive, antiviral
capsid antigen IgM was negative. EBV DNA copy number
was negative (normal range: <10 copies). Staging studies
with chest, abdominal, and pelvis CT scan and bone
marrow biopsy indicated no further extension; erythrocyte2 Case Reports in Medicine
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sedimentation rate was 34mm/hr with an albumin level of
3.8g/dL. Based on these, a diagnosis of classical Hodgkin
lymphoma Cotswold stage IEA was made. He was started on
ABVD chemotherapy (doxorubicin, bleomycin, vinblastine,
anddacarbazine) withplanned durationoftwotofourcycles
before initiation of involved ﬁeld radiotherapy. Figure 5
(coronal STIR) shows the evolution of the lesion after two
cycles of ABVD chemotherapy, with no soft tissue mass
present at the moment. Residual changes in bone marrow
signal intensity can be seen.
2.Discussion
From the subset of malignancies aﬀecting the head and
neck region, lymphomas are the second most frequent after
carcinomas. From those lymphomas, 80% to 90% are Non-
Hodgkin lymphomas and about 4% represent Hodgkin
lymphoma (HL) [1, 2]. The incidence of HL is estimated to
be 7400 new cases per year in the United States, accounting
PHR
Figure 3
for approximately30% ofall lymphomas [3]. Aswell known,
most of the HL involves the lymph nodes. However, under
some circumstances, those tumors arise from tissues other
than the lymph nodes. Trying to deﬁne certain anatomical
area, the term Waldeyer ring is used to include the lymphoid
tissues of the faucial tonsils, nasopharynx, base of tongue,
and oropharynx and therefore is considered an extranodal
but not an extralymphatic site [4]. HL cases arising from this
tissue,althoughuncommon,arebeingwellcharacterized [5].
Therefore, the term extranodal, extralymphatic lymphoma
has been used to describe the uncommon form of lymphoid
malignancy, in which there is neoplastic proliferation at sites
other than the expected native lymph nodes and lymphoid
tissue, respectively. Due to the diﬃculty in case deﬁnition,
the frequency of this type of variation is not well established,
nevertheless when sites rich in primary lymphoid tissue such
as Waldeyer’s ring and spleen are considered extranodal,
extranodal lymphomas would represent 25–50% of all non-
Hodgkin lymphomas and only 2–5% of classical Hodgkin
lymphomas [6]. In the case herein reported, the lymphoma
was localized in the mandible with extension to the buccal
mucosa; both considered outside the boundaries of the
Waldeyer’s ring.
Extranodal, extralymphatic lymphomas from the bone
are uncommon, comprising only 8% of primary malignant
bone tumors and they are mainly diﬀu s eB - c e l lt y p en o n -
Hodgkin lymphomas [7]. This is probably the third case
reported of a primary extranodal and extralymphatic oral
Hodgkin lymphoma of the mandible [8, 9]. There is no
information on the progression of the ﬁrst case [8], but the
second case relapsed 17 months after diagnosis and involved
ﬁeld radiotherapy of the pleura, spleen, liver, and para-
aortic and inguinal lymph nodes, dying 6 months later after
ﬁve cycles of chemotherapy with MOPP regimen (nitrogen,
mustard, vincristine, procarbazine, and prednisone) [9].
Since the applicability of International Prognostic Score is
restricted to advanced stage disease [10], a recent studyCase Reports in Medicine 3
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showed that the absence of tumor associated macrophages
representedbythemarkerCD68,suchinthiscase,isstrongly
correlated with 100% ten-year disease speciﬁc survival [11].
Our case was in complete remission 3 months into therapy.
Weare describingthecourseof thisrareHL presentationand
the favorable early response to standard chemotherapy. This
displayed the wide clinical spectrum that this type of tumor
may encompass. Remarkable still little is known about the
s u r v i v a l ,p r o g n o s i s ,a n de ﬀectiveness of the chemotherapy
for this rare variant.
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